| Cafelkibart | LM-108 | Phase 3 Clinical | LaNova Medicines Ltd | Carcinoma, Non-Small-Cell Lung; Gastroesophageal Junction Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms | 詳細 |
| Imzokitug | BMS-986340; ONO-7427 | Phase 2 Clinical | Eeig Bristol-Myers Squibb Manufacturing Company Bristol-Myers Squibb Srl | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Esophageal Neoplasms; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| TAK- 188 | TAK- 188 | Phase 2 Clinical | Takeda Pharmaceutical Co Ltd | | 詳細 |
| QLP2117 | QLP2117; QLP-2117 | Phase 2 Clinical | Qilu Pharmaceutical Co Ltd | | 詳細 |
| DT-7012 | DT-7012 | Phase 2 Clinical | Domain Therapeutics SA | Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neoplasms; Sezary Syndrome; Solid tumours | 詳細 |
| S-531011 | S-531011 | Phase 2 Clinical | Shionogi Inc | | 詳細 |
| IPG-7236 | IPG-7236 | Phase 2 Clinical | Nanjing Immunophage Biotech Co Ltd | Breast Neoplasms; Dermatitis, Atopic; Solid tumours | 詳細 |
| anti-CCR8 antibody (Bristol-Myers Squibb) | | Phase 1 Clinical | Bristol-Myers Squibb Company | | 詳細 |
| PSB-114 | PSB-114 | Phase 1 Clinical | Qilu Puget Sound Biotherapeutics Corp | | 詳細 |
| BAY-3375968 | BAY-3375968 | Phase 1 Clinical | Bayer AG | | 詳細 |
| ICP-B05 | ICPB05; CM-369 | Phase 1 Clinical | InnoCare Pharma Ltd, Keymed Biosciences Co Ltd | Hematologic Neoplasms; Solid tumours | 詳細 |
| HBM-1022 | HBM-1022 | Phase 1 Clinical | Harbour Biomed | | 詳細 |
| Denikitug | JTX-1811; GS-1811 | Phase 1 Clinical | Jounce Therapeutics Inc | | 詳細 |
| Tagmokitug | CHS-114; SRF-114 | Phase 1 Clinical | Surface Oncology Inc | Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| TQB-6457 | TQB-6457; TQB6457 | Phase 1 Clinical | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co Ltd | | 詳細 |
| KYS-2301 | KYS2301; KYS-2301 | Phase 1 Clinical | Jiangsu Kanion Pharmaceutical Co Ltd | | 詳細 |
| AMG-355 | AMG 355; AMG-355 | Phase 1 Clinical | Amgen Inc | | 詳細 |
| HC-006 | HC-006; HC006 | Phase 1 Clinical | Shanghai Hongcheng Pharmaceutical Co Ltd | | 詳細 |
| BGB-A3055 | BGB-A3055 | Phase 1 Clinical | BeOne Medicines Ltd | | 詳細 |
| ABBV-514 | ABBV-514 | Phase 1 Clinical | Abbvie Inc | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Cystadenocarcinoma, Serous; Ovarian Neoplasms; Pancreatic Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | 詳細 |
| IPGA-05 | IPGA-05; IPG0521; IPG-0521 | Phase 1 Clinical | Nanjing Immunophage Biotech Co Ltd | Autoimmune Diseases; Immunoglobulin G4-Related Disease; Solid tumours | 詳細 |